Pfizer Is The First Covid-19 Vaccine to be Approved in Japan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Singapore Seeking Pharmaceutical Tariff Concessions from US

The deputy prime minister and trade minister of Singapore,...

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Japan’s Health Ministry has approved Pfizer’s Covid-19 vaccine as the Summer Olympic Games begin in July.

The approval marks the first in the country as it steps up efforts to fight the third wave of infections.

After a government panel recommended approval last week, Japanese Health Minister Norihisa Tamura said the country would approve the vaccine soon, Reuters reported.

The news agency quoted Prime Minister Yoshihide Suga as saying that inoculations will start from the middle of next week, beginning with some 10,000 health workers.

Furthermore, the government plans to obtain enough vaccine doses for its populace of around 126 million by mid-year.

After Japan’s third and most deadly wave of the virus hit late last year, many areas in the country are still under a state of emergency.

Separately, the Drug Regulatory Authority of Pakistan (DRAP) approved the emergency use of Chinese company Cansino Biologics’ Covid-19 vaccine, making it the fourth drug cleared by the regulatory authority to fight against the virus.

This is the second Chinese vaccine approved by the country and the supply of the doses will begin soon.

Latest stories

Related stories

Singapore Seeking Pharmaceutical Tariff Concessions from US

The deputy prime minister and trade minister of Singapore,...

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back